The George Institute clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   CAPTIVATE · Chronic Kidney Disease Adaptive Platform Trial…CAPTIVATE · Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

   Primary completion pushed from Aug 30, 2028 to Dec 31, 2029

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 1000 → 2000 participants

   The George Institute·Phase 3· NCT06058585· Registry history of NCT06058585 on ClinicalTrials.gov (opens the registry)

   Updated Oct 5, 2026

2. Notable

   Ue-STAR · Ultra-early STatin · Aneurysmal subaRachnoid Hemorrhage…Ue-STAR · Ultra-early STatin · Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)

   Trial status changed: Unknown → Withdrawn

   Sponsor's reason: Funding issues.

   And 1 more change in the last 30 days

   The George Institute·Phase 3· NCT06559072· Registry history of NCT06559072 on ClinicalTrials.gov (opens the registry)

   Updated Oct 5, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.